Clinical Report: Increased Plasma Cholesterol Levels Enhance Survival in Sepsis

Overview

Expand on the mechanistic investigations to specify the types of hepatic metabolic changes observed.

Background

Incorporate specific statistics or references to support the claims regarding hypocholesterolemia and its association with sepsis outcomes.

Data Highlights

Key Findings

• Survivors of sepsis had significantly higher cholesterol levels compared to non-survivors (median 135 vs. 126 mg/dL).
• High cholesterol levels (≥133 mg/dL) were independently associated with reduced 28-day mortality (adjusted HR = 0.80).
• Mice on a high-cholesterol diet showed improved survival rates (52.5% to 90%) after sepsis induction.
• Metabolic reprogramming in the liver was observed with enhanced oxidative phosphorylation and antioxidant pathways.
• Inhibition of mitochondrial respiration negated the survival benefits associated with high cholesterol.

Clinical Implications

Clinicians should consider the potential protective role of cholesterol in sepsis management and the need for further research into lipid-modifying therapies. Understanding the metabolic pathways influenced by cholesterol may lead to innovative treatment strategies that enhance patient resilience during severe infections.

Conclusion

Elevated plasma cholesterol levels are linked to improved survival in sepsis, likely through metabolic reprogramming in the liver. Targeting these pathways may offer new therapeutic avenues in sepsis care.

Related Resources & Content

1. Critical Care (Springer), 2025 -- Effect of therapeutic plasma exchange on acquired hypocholesterolemia in patients with septic shock
2. Critical Care (Springer), 2025 -- Reduced plasma levels of Copine 5 correlate with sepsis-induced vascular leakage and mortality
3. Critical Care (Springer), 2025 -- Sepsis-induced hypocholesterolemia is linked to low cardiomyocyte membrane cholesterol
4. Critical Care (Springer), 2025 -- High-density lipoprotein: a biomarker and therapeutic target in sepsis
5. Surviving Sepsis Campaign Adult Guidelines | SCCM, 2026 -- Guidelines and resources
6. High-density lipoprotein: a biomarker and therapeutic target in sepsis
7. Statin use during intensive care unit stay is associated with improved clinical outcomes in critically ill patients with sepsis
8. Surviving Sepsis Campaign Adult Guidelines | SCCM